Little Green Pharma receives manufacturing licence for new cannabis facility

Little Green Pharma receives manufacturing licence for new cannabis facility

Little Green Pharma (ASX: LGP) has today received a manufacturing licence from the Therapeutic Goods Association (TGA), enabling it to manufacture medicinal cannabis in-house at its new Western Australia-based facility.

Receipt of the licence means LGP's new facility in WA can operate in-house manufacturing of medicinal cannabis, avoiding competition for outsourced manufacturing services.

It will also enable the company to focus on identifying further manufacturing cost efficiencies and expedite inspection and auditing processes by offshore distributors.

The new facility in WA was completed in March and is able to produce more than 100,000 bottles of medicinal cannabis oil each year.


Australia's top 20 cannabis companies


"The grant represents the culmination of LGP's long-term regulatory strategy and is a clear watershed moment for the company," said LGP managing director Fleta Solomon.

"The grant of this GMP licence differentiates the company as the only fully TGA and ODC licenced and permitted medicinal cannabis company on the ASX with local Australian cultivation, manufacturing and wholesaling capacity, as well as brands in the market.

"This end-to-end supply capability allows us to more effectively manage costs, focus on higher-margin aspects of the supply chain, and supply LGP-branded GMP-grade medicinal cannabis products into the highly regulated markets of the European Union."

The company now plans to develop additional GMP-licenced cannabis products and other pharmaceutical formulations, and potentially offer extraction and manufacturing services to other cannabis producers.

Shares in LGP are up 13.79 per cent to $0.33 per share at 12.44pm AEDT.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Interest rates: To fix or not to fix?
Partner Content
Interest rates are on the move as evidenced by another rise issued by the Reserve Bank ...
WMS
Advertisement

Related Stories

Deloitte report paints rosy M&A future despite prevailing economic headwinds

Deloitte report paints rosy M&A future despite prevailing economic headwinds

Most corporate leaders of M&A divisions across Australia and Ne...

China leads the rapid offshore growth boosting Blackmores’ full-year profit

China leads the rapid offshore growth boosting Blackmores’ full-year profit

Vitamins and supplements giant Blackmores Group’s (ASX: BKL) ...

Penfolds owner Treasury Wines delivers improved profit while flagging price increases

Penfolds owner Treasury Wines delivers improved profit while flagging price increases

Treasury Wines (ASX: TWE), the owner of major wine labels including...

ACCC concerned Qantas’ acquisition of Alliance would lessen FIFO competition

ACCC concerned Qantas’ acquisition of Alliance would lessen FIFO competition

Australia’s competition watchdog has today raised preliminary...